Antidepressants

What if your doctor told you about data collected on antidepressants AFTER they had been released on the market. New Zealand data that shows aggression and death are as common as dizziness in reports from doctors about adverse reactions to antidepressants. That suicidal ideation and suicide attempt are as common as insomnia. Imagine you were told that while being exposed to these risks, the data showed that the most likely adverse reaction you would experience would be that the drug didn't work or stopped working. How might your decision on this particular treatment option be affected?

In a bellwether case, plaintiffs allege that Pfizer did not adequately warn patients that Zoloft (sertraline) would cause birth defects. The case is scheduled in Federal Court in March, and the verdict will have significant implications for future suits.

David Kupelian writes "Two-and-a-half years ago, a groundbreaking peer-reviewed study out of California-based Kaiser Permanente documented a significantly increased prevalence of children born with autism...

Chuck Norris writes in WND: "I believe that too many who struggle with mild cases of depression don’t think they can find genuine relief...

Accumulating evidence points to serious risks associated with antidepressant use during pregnancy, yet data suggests that prescriptions continue to rise in the US. "Given...

With the American Medical Association (AMA) declaring its opposition to direct-to-consumer (DTC) drug advertising, Martha Rosenberg asks, did DTC increase the number of people who have "diseases"?

A new study in JAMA reveals that, on average, 25% of beginning physicians meet the diagnostic criteria for major depression. In an accompanying editorial, Dr. Thomas Schwenk, added: "Everybody asks me, because of some of my prior studies, should we have more intense work in diagnosing depression in students? Of course, the answer is 'yes,' but how do you go about that without further stigmatizing them, further labeling them, further singling them out to even greater stigma? It's not just an issue of, 'Let's make better diagnoses and let's provide better treatment'; it’s more complicated than that."

Researchers from the State University of New York at Buffalo (UB) found that antidepressants weaken bone growth which can disrupt procedures like tooth implants....

Last week, after the US Preventative Services Task Force (USPSTF) made a recommendation for increased mental health and depression screening “stories in the New York Times,...

Despite concerns about the drug’s necessity, effectiveness, and side-effects, Flibanserin (Addyi) has come to market as the first drug designed to increase sexual desire in women

-Salon assistant editor Joanna Rothkopf describes her year of failed efforts to get off the antidepressant Zoloft.

On October 23, the New York Times ran a very nice feature story about a Los Angeles woman, Keris Myrick, who, even though she...

The Wall Street Journal highlights a new study that found that off-label medications represent about 12% of drug prescriptions and are resulting in negative...

Writing for the Harvard Health Blog, Dr. Nandinia Mani reconsiders the use of antidepressants in teens in light of the reanalysis of Study 329. ...

From youtube: Published on Sep 17, 2013 SSRIs: More Harm Than Good Selective serotonin reuptake inhibitor ( SSRI ) Researchers found that antidepressants hinder serotonin regulation and can cause...

"Depression can double risk of stroke," reported many news outlets, covering a study by Harvard School of Public Health researchers in the Journal of the American Heart Association

-Correspondence in The Lancet Psychiatry suggests that a study linking depression to acts of violence should have examined antidepressant medications as possible causes.

Jim Gottstein’s presentation March 29, 2012 at the APA’s Humanistic Division. Mr. Gottstein talks about the the legal and moral issues of the massive number...

A new review finds that mindfulness-based cognitive therapy (MBCT) can help stave off recurring depression as effectively as antidepressants. People suffering from depression who...

An article in the Wall Street Journal today explores the phenomenon of children growing up on antidepressants. Article → 

The UK Times reports that pharmaceutical companies are actively lobbying to limit the release of clinical trial data to the public. Rather than limiting results and data to medical journals, new transparency initiatives are pushing for making the information publically available. The push for transparency comes in the wake of the reanalysis of the Study 329 data on paroxetine (marketed as Seroxat and Paxil), which found that the industry study had misconstrued its results.

Psychiatric Times has published a discussion of the research comparing the effectiveness of antidepressant medications under different conditions. “First, there seem to be no...

Bob Fiddamen dissects the issue of suicidality, bizarre behavior and antidepressants in light of BMJ Open's publication of "Suicide-related events in young people following...

An article in the New England Journal of Medicine asks whether settlements such as the $3 billion GlaxoSmithKline agreed to last July regarding off-label...

The defense phase of the trial of Anthony Nicholas Orban begins on Monday, with Mr. Orban's lawyer presenting evidence that Orban was so overwhelmed...